Buy NVAX by Aug 4, 2026.

A few weeks ago I wrote that Nvax just needs a catalyst. The earnings have exceeded expectations spectacularly, 139 million in revenue vs 78 mil expected. As it stands now, the stats are almost all where we want them: Short interest at 33% Days to cover at 17 days Off-exchange short interest at staggering 63% Shares available to borrow: 150 000. This is the lowest I've seen in a long time, usually its in the 500 000 range Cost to …